J&J expects jump in COVID vaccine sales in 2022, eyes device deals

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/18/2026

1. SPY
2. FLNC
3. CRM
4. GNRC
5. CRWV
6. NVDA
7. USO
8. LMT
9. TLT
10. AMZN

Go back to J&J expects jump in COVID vaccine sales in 2022, eyes device deals

Johnson & Johnson (JNJ) PT Raised to $163 at Goldman Sachs

January 26, 2022 7:36 AM EST

Goldman Sachs analyst Chris Shibutani raised the price target on Johnson & Johnson (NYSE: JNJ) to $163.00 (from $161.00) while maintaining a Neutral rating.

... More